A molecular epidemiological study of the hepatitis B virus in Thailand after 22 years of universal immunization

Journal of Medical Virology

Volumn 88, Issue 4, 2016, Pages 664-673

  Yimnoi, Parichat ^a   Posuwan, Nawarat ^a   Wanlapakorn, Nasamon ^a   Tangkijvanich, Pisit ^a   Theamboonlers, Apiradee ^a   Vongpunsawad, Sompong ^a   Poovorawan, Yong ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

"a" determinant; EPI; Genotype; Hepatitis B virus (HBV); Mutations

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; VIRUS DNA; HEPATITIS B CORE ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DNA SEQUENCE; DRUG EFFICACY; FEMALE; GENE AMPLIFICATION; GENOTYPE; HEALTH CARE DELIVERY; HEALTH SURVEY; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS B VIRUS GENOTYPE B; HEPATITIS B VIRUS GENOTYPE C; HUMAN; INFANT; MALE; MASS IMMUNIZATION; MOLECULAR EPIDEMIOLOGY; NEWBORN; NONHUMAN; POLYMERASE CHAIN REACTION; PROMOTER REGION; SEQUENCE ALIGNMENT; SEROPREVALENCE; THAILAND; VIRUS CARRIER; VIRUS MUTATION; CHEMISTRY; CLASSIFICATION; GENETICS; HETEROZYGOTE; ISOLATION AND PURIFICATION; MIDDLE AGED; PRESCHOOL CHILD; PREVENTION AND CONTROL; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; CARRIER STATE; CHILD; CHILD, PRESCHOOL; DNA, VIRAL; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; INFANT; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; SEQUENCE ANALYSIS, DNA; THAILAND; YOUNG ADULT;

EID: 84955641342     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.24368     Document Type: Article

References (39)

1. Abdo AA, Al-Jarallah BM, Sanai FM, Hersi AS, Al-Swat K, Azzam NA, Al-Dukhayil M, Al-Maarik A, Al-Faleh FZ. 2006. Hepatitis B genotypes: Relation to clinical outcome in patients with chronic hepatitis B in Saudi Arabia. World J Gastroenterolo 12:7019-7024.
2. Allain JP. 2006. Epidemiology of Hepatitis B virus and genotype. J Clin Virol 36:S12-S17.
3. Bozdayi G, Turkyilmaz AR, Idilman R, Karatayli E, Rota S, Yurdaydin C, Bozdayi AM. 2005. Complete genome sequence and phylogenetic analysis of hepatitis B virus isolated from Turkish patients with chronic HBV infection. J Med Virol 76:476-481.
4. Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, Zuckerman AJ, Thomas HC. 1990. Vaccine-induced escape mutant of hepatitis B virus. Lancet 336:325-329.
5. Chen BF, Liu CJ, Jow GM, Chen PJ, Kao JH, Chen DS. 2006. High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases. Gastroenterology 130:1153-1168.
6. Chiou HL, Lee TS, Kuo J, Mau YC, Ho MS. 1997. Altered antigenicity of 'a' determinant variants of hepatitis B virus. J Gen Virol 78:2639-2645.
7. Deterding K, Constantinescu I, Nedelcu FD, Gervain J, Nemecek V, Srtunecky O, Vince A, Grgurevic I, Bielawski KP, Zalewska M, Bock T, Ambrozaitis A, Stanczak J, Takacs M, Chulanov V, Slusarczyk J, Drazd'akova M, Wiegand J, Cornberg M, Manns MP, Wedemeyer H. 2008. Prevalence of HBV genotypes in Central and Eastern Europe. J Med Virol 80:1707-1711.
8. Ganem D, Prince AM. 2004. Hepatitis B virus infection-natural history and clinical consequences. N Engl J Med 350:1118-1129.
9. Garmiri P, Loua A, Haba N, Candotti D, Allain JP. 2009. Deletions and recombinations in the core region of hepatitis B virus genotype E strains from asymptomatic blood donors in Guinea, west Africa. J Gen Virol 90:2442-2451.
10. Hsu HY, Chang MH, Ni YH, Chen HL. 2004. Survey of hepatitis B surface variant infection in children 15 years after a nationwide vaccination programme in Taiwan. Gut 53:1499-1503.
11. Hsu HY, Chang MH, Ni YH, Chiang CL, Chen HL, Wu JF, Chen PJ. 2010. No increase in prevalence of hepatitis B surface antigen mutant in a population of children and adolescents who were fully covered by universal infant immunization. J Infect Dis 201:1192-1200.
12. Hubschen JM, Andernach IE, Muller CP. 2008. Hepatitis B virus genotype E variability in Africa. J Clin Virol 43:376-380.
13. Kao JH, Chen PJ, Lai MY, Chen DS. 2000. Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology 118:554-559.
14. Kay A, Zoulim F. 2007. Hepatitis B virus genetic variability and evolution. Virus Res 127:164-176.
15. Kramvis A, Kew MC. 2007. Epidemiology of hepatitis B virus in Africa, its genotypes and clinical associations of genotypes. Hepatology 37:S9-S19.
16. Liu CJ, Kao JH, Shau WY, Chen PJ, Lai MY, Chen DS. 2002. Naturally occurring hepatitis B surface gene variants in chronic hepatitis B virus infection: Correlation with viral serotypes and clinical stages of liver disease. J Med Virol 68:50-59.
17. Livingston SE, Simonetti JP, McMahon BJ, Bulkow LR, Hurlburt KJ, Homan CE, Snowball MM, Cagle HH, Williams JL, Chulanov VP. 2007. Hepatitis B virus genotypes in Alaska Native people with hepatocellular carcinoma: preponderance of genotype F. J Infect Dis 195:5-11.
18. Lok AS. 2000. Hepatitis B infection: Pathogenesis and management. J Hepatol 32:89-97.
19. McMahon BJ. 2009. The influence of hepatitis B virus genotype and subgenotype on the natural history of chronic hepatitis B. Hepatol Int 3:334-342.
20. Milich D, Liang TJ. 2003. Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection. Hepatology 38:1075-1086.
21. Norder H, Courouce AM, Coursaget P, Echevarria JM, Lee SD, Mushahwar IK, Robertson BH, Locarnini S, Magnius LO. 2004. Genetic diversity of hepatitis B virus strains derived worldwide: Genotypes, subgenotypes, and HBsAg subtypes. Intervirology 47:289-309.
22. Norder H, Hammas B, Lofdahl S, Courouce AM, Magnius LO. 1992. Comparison of the amino acid sequences of nine different serotypes of hepatitis B surface antigen and genomic classification of the corresponding hepatitis B virus strains. J Gen Virol 73:1201-1208.
23. Okamoto H, Tsuda F, Akahane Y, Sugai Y, Yoshiba M, Moriyama K, Tanaka T, Miyakawa Y, Mayumi M. 1994. Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen. J Virol 68:8102-8110.
24. Osiowy C, Gordon D, Borlang J, Giles E, Villeneuve JP. 2008. Hepatitis B virus genotype G epidemiology and co-infection with genotype A in Canada. J Gen Virol 89:3009-3015.
25. Payungporn S, Tangkijvanich P, Jantaradsamee P, Theamboonlers A, Poovorawan Y. 2004. Simultaneous quantitation and genotyping of hepatitis B virus by real-time PCR and melting curve analysis. J Virol Methods 120:131-140.
26. Pollicino T, Zanetti AR, Cacciola I, Petit MA, Smedile A, Campo S, Sagliocca L, Pasquali M, Tanzi E, Longo G, Raimondo G. 1997. Pre-S2 defective hepatitis B virus infection in patients with fulminant hepatitis. Hepatology 26:495-499.
27. Poovorawan Y, Chongsrisawat V, Theamboonlers A, Crasta PD, Messier M, Hardt K. 2013. Long-term anti-HBs antibody persistence following infant vaccination against hepatitis B and evaluation of anamnestic response: A 20-year follow-up study in Thailand. Hum Vaccin Immunother 9:1679-1684.
28. Poovorawan Y, Theamboonlers A, Chongsrisawat V, Sanpavat S. 1998. Molecular analysis of the a determinant of HBsAg in children of HBeAg-positive mothers upon failure of postexposure prophylaxis. Int J Infect Dis 2:216-220.
29. Poovorawan Y, Theamboonlers A, Vimolket T, Sinlaparatsamee S, Chaiear K, Siraprapasiri T, Khwanjaipanich S, Owatanapanich S, Hirsch P, Chunsuttiwat S. 2000. Impact of hepatitis B immunisation as part of the EPI. Vaccine 19:943-949.
30. Purcell RH. 2000. Hepatitis B virus mutants and efficacy of vaccination. Lancet 356:769-770.
31. Sa-Nguanmoo P, Tangkijvanich P, Tharmaphornpilas P, Rasdjarmrearnsook AO, Plianpanich S, Thawornsuk N, Theamboonlers A, Poovorawan Y. 2012. Molecular analysis of hepatitis B virus associated with vaccine failure in infants and mothers: A case-control study in Thailand. J Med Virol 84:1177-1185.
32. Sakamoto T, Tanaka Y, Orito E, Co J, Clavio J, Sugauchi F, Ito K, Ozasa A, Quino A, Ueda R, Sollano J, Mizokami M. 2006. Novel subtypes (subgenotypes) of hepatitis B virus genotypes B and C among chronic liver disease patients in the Philippines. J Gen Virol 87:1873-1882.
33. Schaefer S. 2007. Hepatitis B virus genotypes in Europe. Hepatology Res 37:S20-S26.
34. Sumi H, Yokosuka O, Seki N, Arai M, Imazeki F, Kurihara T, Kanda T, Fukai K, Kato M, Saisho H. 2003. Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease. Hepatology 37:19-26.
35. Sunbul M. 2014. Hepatitis B virus genotypes: Global distribution and clinical importance. World J Gastroenterol 20:5427-5434.
36. Suwannakarn K, Tangkijvanich P, Thawornsuk N, Theamboonlers A, Tharmaphornpilas P, Yoocharoen P, Chongsrisawat V, Poovorawan Y. 2008. Molecular epidemiological study of hepatitis B virus in Thailand based on the analysis of pre-S and S genes. Hepatology Res 38:244-251.
37. Theamboonlers A, Chongsrisawat V, Jantaradsamee P, Poovorawan Y. 2001. Variants within the "a" determinant of HBs gene in children and adolescents with and without hepatitis B vaccination as part of Thailand's expanded program on immunization (EPI). Tohoku J Exp Med 193:197-205.
38. Weinbaum CM, Williams I, Mast EE, Wang SA, Finelli L, Wasley A, Neitzel SM, Ward JW. 2008. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. Hepatology 49:S35-S44.
39. Zuckerman JN, Zuckerman AJ. 2003. Mutations of the surface protein of hepatitis B virus. Antiviral Res 60:75-78.